Harnessing PD-L1-specific cytotoxic T cells for anti-leukemia immunotherapy to defeat mechanisms of immune escape mediated by the PD-1 pathway

Leukemia. 2014 Jan;28(1):236-8. doi: 10.1038/leu.2013.261. Epub 2013 Sep 12.

Authors

S M Ahmad¹, S K Larsen¹, I M Svane¹, M H Andersen¹

Affiliation

¹ Center for Cancer Immune Therapy (CCIT), Department of Hematology and Oncology, Copenhagen University Hospital, Herlev, Denmark.

PMID: 24091833
DOI: 10.1038/leu.2013.261

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

B7-H1 Antigen / physiology*
Humans
Immunotherapy*
Leukemia / immunology
Leukemia / therapy*
T-Lymphocytes, Cytotoxic / immunology*
Tumor Escape*

Substances

B7-H1 Antigen
CD274 protein, human